Jeremy N. Burrows - Concepedia

Author

Jeremy N. Burrows

Also Known As

Burrows, J.N., Burrows, Jeremy, Burrows, Jeremy N., Dennis W. Juma2, J. N. BURROWS, J.N. Burrows, JEREMY N BURROWS, Jeremy Burrows, Jeremy N Burrows, Jeremy N. Burrows

183

Publications

9.5K

Citations

H-Index

Concepts

All Affiliations

Medicines for Malaria Venture Monash University GlaxoSmithKline (Spain)Swiss Tropical and Public Health Institute University of Basel

About

Jeremy N. Burrows is an author at Medicines for Malaria Venture specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	29	2.4K
2	Biochemistry	21	25	2.1K
3	Natural Sciences	20	23	1.9K
4	Engineering	7	7	211
5	Biomolecular Engineering	6	6	277

Jeremy N. Burrows

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond Wesley C. Van Voorhis, John H. Adams, Roberto Adelfio, PLoS Pathogens Drug TargetBioorganic ChemistryAntiparasitic AgentMalariaMedicinal Chemistry	2016	441
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria Margaret A. Phillips, Julie Lotharius, Kennan C. Marsh, Science Translational Medicine	2015	367
The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases Thomas Spangenberg, Jeremy N. Burrows, Paul Kowalczyk, PLoS ONE Selection MethodologyMedicinal ChemistryDrug RepositioningBioorganic ChemistryPlasmodium Falciparum	2013	333
Quinolone-3-Diarylethers: A New Class of Antimalarial Drug Aaron Nilsen, Alexis N. LaCrue, Karen L. White, Science Translational Medicine	2013	296
Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent<i>Plasmodium falciparum</i>Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential José M. Coterón, María Marco, Jorge Esquivias, Journal of Medicinal Chemistry	2011	280
Antimalarial efficacy of MMV390048, an inhibitor of <i>Plasmodium</i> phosphatidylinositol 4-kinase Tanya Paquet, Claire Le Manach, Diego González Cabrera, Science Translational Medicine	2017	262
P. falciparum In Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action Laura M. Sanz, Benigno Crespo, Cristina De-Cózar, PLoS ONE Antiparasitic AgentMalariaCell DeathParasite GenomicsParasite Viability	2012	223
Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis J. Stone Doggett, Aaron Nilsen, Isaac Forquer, Proceedings of the National Academy of Sciences	2012	187
Lead Optimization of Aryl and Aralkyl Amine-Based Triazolopyrimidine Inhibitors of<i>Plasmodium falciparum</i>Dihydroorotate Dehydrogenase with Antimalarial Activity in Mice Ramesh Gujjar, Farah El Mazouni, Karen L. White, Journal of Medicinal Chemistry	2011	165
Fragment screening: an introduction Andrew R. Leach, Michael M. Hann, Jeremy N. Burrows, Molecular BioSystems Hit IdentificationLead IdentificationChemistryChemical BiologyFragment Screen	2006	161

Page 1